| Oct 31 |
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
|
| Oct 31 |
Matinas BioPharma plunges as deal for lead asset falls apart
|
| Oct 31 |
Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction
|
| Sep 2 |
Upcoming Stock Splits This Week (September 2 to September 6) – Stay Invested
|
| Aug 7 |
Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024
|
| Jul 15 |
Looking Into Matinas BioPharma Hldgs's Recent Short Interest
|
| May 16 |
New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Presented at TIDES USA 2024
|
| May 9 |
Matinas BioPharma Holdings, Inc. (MTNB) Q1 2024 Earnings Call Transcript
|
| May 9 |
Matinas Biopharma GAAP EPS of -$0.03 in-line, no revenue
|
| May 9 |
Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update
|
